Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 2
2006 1
2007 2
2008 1
2009 2
2011 1
2012 4
2013 4
2014 2
2016 2
2019 1
2020 3
2021 5
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
Nicolosi A, Gaia S, Risso A, Rosso C, Rolle E, Abate ML, Olivero A, Armandi A, Ribaldone DG, Carucci P, Fagoonee S, Pellicano R, Saracco GM, Bugianesi E, Caviglia GP. Nicolosi A, et al. Among authors: carucci p. Minerva Gastroenterol (Torino). 2022 Dec;68(4):378-386. doi: 10.23736/S2724-5985.21.03006-0. Epub 2022 Oct 12. Minerva Gastroenterol (Torino). 2022. PMID: 36222678
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis.
Di Maira G, Foglia B, Napione L, Turato C, Maggiora M, Sutti S, Novo E, Alvaro M, Autelli R, Colombatto S, Bussolino F, Carucci P, Gaia S, Rosso C, Biasiolo A, Pontisso P, Bugianesi E, Albano E, Marra F, Parola M, Cannito S. Di Maira G, et al. Among authors: carucci p. J Pathol. 2022 May;257(1):82-95. doi: 10.1002/path.5871. Epub 2022 Mar 7. J Pathol. 2022. PMID: 35064579 Free PMC article.
Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma.
Rognoni C, Barcellona MR, Bargellini I, Bavetta MG, Bellò M, Brunetto M, Carucci P, Cioni R, Crocetti L, D'Amato F, D'Amico M, Deagostini S, Deandreis D, De Simone P, Doriguzzi A, Finessi M, Fonio P, Grimaldi S, Ialuna S, Lagattuta F, Masi G, Moreci A, Scalisi D, Virdone R, Tarricone R. Rognoni C, et al. Among authors: carucci p. Front Oncol. 2022 Aug 29;12:920073. doi: 10.3389/fonc.2022.920073. eCollection 2022. Front Oncol. 2022. PMID: 36106105 Free PMC article.
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease.
Caviglia GP, Nicolosi A, Abate ML, Carucci P, Rosso C, Rolle E, Armandi A, Aneli S, Olivero A, Risso A, Ribaldone DG, Fermer C, Saracco GM, Gaia S, Bugianesi E. Caviglia GP, et al. Among authors: carucci p. Curr Oncol. 2022 Jul 31;29(8):5457-5465. doi: 10.3390/curroncol29080431. Curr Oncol. 2022. PMID: 36005169 Free PMC article.
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development.
Caviglia GP, Abate ML, Troshina G, Carucci P, Rolle E, Risso A, Burlone ME, Albè A, Crevola M, Musso EC, Rosso C, Armandi A, Olivero A, Minisini R, Saracco GM, Bugianesi E, Pirisi M, Ciancio A, Gaia S. Caviglia GP, et al. Among authors: carucci p. Biology (Basel). 2023 Jan 7;12(1):94. doi: 10.3390/biology12010094. Biology (Basel). 2023. PMID: 36671786 Free PMC article.
36 results